Whistle-blowers' experiences in fraud litigation against pharmaceutical companies

New England Journal of Medicine

Volumn 362, Issue 19, 2010, Pages 1832-1839

  Kesselheim, Aaron S ^a   Studdert, David M ^c   Mello, Michelle M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; ATORVASTATIN; CICLOPIROXOLAMINE; CIPROFLOXACIN; FAMOTIDINE; FENTANYL CITRATE; GABAPENTIN; GAMMA1B INTERFERON; GOSERELIN; GRANISETRON; HUMAN GROWTH HORMONE; LEUPRORELIN; LEVOTHYROXINE SODIUM; LORATADINE; METFORMIN; MODAFINIL; NIFEDIPINE; OLANZAPINE; ONDANSETRON; OXYBATE SODIUM; PEGADEMASE; PRAVASTATIN; RAMIPRIL; ROFECOXIB; TIAGABINE;

ARTICLE; DRUG INDUSTRY; DRUG MARKETING; FORGERY; HEALTH CARE; HEALTH CARE POLICY; LEGAL ASPECT; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; WHISTLEBLOWING; ETHICS; HUMAN; JURISPRUDENCE; MOTIVATION; PSYCHOLOGICAL ASPECT; UNITED STATES;

DRUG INDUSTRY; FRAUD; HUMANS; JURISPRUDENCE; MOTIVATION; UNITED STATES; WHISTLEBLOWING;

EID: 77952294950     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr0912039     Document Type: Article

References (22)

1. Iglehart JK. Finding money for health care reform - rooting out waste, fraud, and abuse. N Engl J Med 2009;361:229-231
2. Health insurance: vulnerable payers lose billions to fraud and abuse. Washington, DC: General Accounting Office, May 1992. (Publication no. GAO/HRD-92-69.) (Accessed April 22, 2010, at http://archive.gao.gov/t2pbat6/ 146547.pdf.)
3. Sparrow MK. License to steal: how fraud bleeds America's health care system. Boulder, CO: Westview Press, 2000.
4. Harris G. Pfizer pays $2.3 billion to settle marketing case. New York Times. September 2, 2009:B4.
5. Fraud statistics - overview: October 1, 1986, to September 30, 2007. Washington, DC: Civil Division, Department of Justice, November 2007. (Accessed April 22, 2010, at http://www.taf.org/STATS-FY-2007.pdf.)
6. Kesselheim AS, Studdert DM. Whistleblower-initiated enforcement actions against health care fraud and abuse in the United States, 1996-2005. Ann Intern Med 2008;149:342-349
7. Meyer JA. Fighting Medicare fraud: more bang for the federal buck. Washington, DC: Taxpayers against Fraud, July 2006. (Accessed April 22, 2010, at http://www.taf.org/FCA-2006report.pdf.)
8. Becker D, Kessler D, McClellan M. Detecting Medicare abuse. J Health Econ 2005;24:189-210.
9. Lenzer J. What can we learn from medical whistleblowers? PLoS Med 2005;2(7):e209.
10. Rost P. The whistleblower: confessions of a health care hitman. Brooklyn, NY: Soft Skull Press, 2006.
11. Alford CF. Whistleblowers: broken lives and organizational power. Ithaca, NY: Cornell University Press, 2002.
12. Glazer MP, Glazer PM. The whistleblowers: exposing corruption in government and industry. New York: Basic Books, 1989.
13. Brenner M. The man who knew too much. Vanity Fair. May 1996:170-192
14. Glazer M. Ten whistleblowers and how they fared. Hastings Cent Rep 1983;13(6):33-41.
15. Mello MM, Studdert DM, Brennan TA. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med 2009;360:1557-1566
16. Sandburg B. Health care fraud investigations bedevil Pharma industry: if you're not under investigation, it's only because you've recently settled. The Pink Sheet. November 16, 2009:21-24 (Bridgewater, NJ: Elsevier Business Intelligence.)
17. Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz HM. A qualitative study of increasing beta-blocker use after myocardial infarction: why do some hospitals succeed? JAMA 2001;285:2604-2611
18. Willms DG, Best JA, Taylor DW, et al. A systematic approach for using qualitative methods in primary prevention research. Med Anthropol Q 1990;4:391-409.
19. Devine T. The whistleblower's survival guide: courage without martyrdom. Washington, DC: Fund for Constitutional Government, 1997.
20. Charles S. Medical liability litigation as a disruptive life event. Bull Am Coll Surg 2005;90:17-23.
21. Studdert DM, Mello MM, Sage WM, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA 2005;293:2609-2617 (Pubitemid 40741199)
22. Sen. Grassley: over 1,000 healthcare fraud cases await government action. Hospital Review. October 12, 2009. (Accessed April 22, 2010, at http://www.hospitalreviewmagazine.com/news-and-analysis/legal-and-regulatory/ sen-grassley-over-1000-healthcare-fraud-cases-await-government-action.html.)